Skip to main navigation
Skip to search
Skip to main content
Wageningen University & Research Home
Contact & Help
Home
Profiles
Research units
Research output
Datasets
Projects
Press/Media
Activities
Prizes
Search by expertise, name or affiliation
Novel targets for the development of drugs for Type 2 Diabetes Mellitus
Alexandros Sotiriou
Toxicology
VLAG
Research output
:
Thesis
›
internal PhD, WU
Overview
Fingerprint
Projects
(1)
Fingerprint
Dive into the research topics of 'Novel targets for the development of drugs for Type 2 Diabetes Mellitus'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
TLR4
100%
Adipocyte
83%
Gene Expression
50%
Downregulation
50%
Peroxisome Proliferator-Activated Receptor
33%
Reporter Gene
33%
IC50
16%
3T3-L1
16%
Macrophage
16%
RNA Sequence
16%
Insulin Sensitivity
16%
Insulin Resistance
16%
Metabolic Disorder
16%
PPAR Agonist
16%
EC50
16%
Hope
16%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Toll Like Receptor 4
50%
Adipocyte
41%
Gene Expression
25%
down Regulation
25%
Antidiabetic Agent
25%
Peroxisome Proliferator Activated Receptor
16%
Reporter Gene
16%
Cell Line
16%
In Vitro
8%
Biological Marker
8%
Food Intake
8%
Bioassay
8%
Insulin Sensitivity
8%
Water-Electrolyte Imbalance
8%
Diabetes Mellitus
8%
Peroxisome Proliferator Activated Receptor Agonist
8%
Insulin Resistance
8%
Macrophage
8%
Visceral Fat
8%
RNA Sequence
8%
IC50
8%
3T3-L1
8%
Hope
8%
Diseases
8%
Pharmacology, Toxicology and Pharmaceutical Science
Resistin
100%
Non Insulin Dependent Diabetes Mellitus
100%
Toll Like Receptor 4
50%
Antidiabetic Agent
25%
Peroxisome Proliferator Activated Receptor
16%
RNA-Sequencing
8%
Energy Conservation
8%
PPAR Agonist
8%
Biological Marker
8%
Inflammation
8%
Insulin Resistance
8%
Diabetes Mellitus
8%
IC50
8%
EC50
8%
Diseases
8%
Metabolic Disorder
8%
Immunology and Microbiology
Resistin
100%
TLR4
50%
Adipocyte
41%
Gene Expression
25%
Downregulation
25%
Insulin
25%
Cell Line
16%
Reporter Gene
16%
Macrophage
8%
EC50
8%
RNA Sequence
8%
Insulin Resistance
8%
Insulin Sensitivity
8%
Agonist
8%
IC50
8%